142 related articles for article (PubMed ID: 11035197)
1. Transdermal delivery of antisense compounds.
Brand RM; Iversen PL
Adv Drug Deliv Rev; 2000 Oct; 44(1):51-7. PubMed ID: 11035197
[TBL] [Abstract][Full Text] [Related]
2. Topical and transdermal delivery of antisense oligonucleotides.
Brand RM
Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of phosphorodiamidate Morpholino oligomers across hairless mouse skin.
Pannier AK; Arora V; Iversen PL; Brand RM
Int J Pharm; 2004 May; 275(1-2):217-26. PubMed ID: 15081152
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of antisense oligonucleotides.
Brand RM; Iversen PL
Methods Mol Med; 2005; 106():255-69. PubMed ID: 15375321
[No Abstract] [Full Text] [Related]
5. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo.
Brand RM; Hannah TL; Norris J; Iversen PL
Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):1-6. PubMed ID: 11258617
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic delivery of a telomeric oligonucleotide.
Brand RM; Iversen PL
Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
[TBL] [Abstract][Full Text] [Related]
8. Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin.
Dokka S; Cooper SR; Kelly S; Hardee GE; Karras JG
J Invest Dermatol; 2005 May; 124(5):971-5. PubMed ID: 15854038
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.
Lin W; Cormier M; Samiee A; Griffin A; Johnson B; Teng CL; Hardee GE; Daddona PE
Pharm Res; 2001 Dec; 18(12):1789-93. PubMed ID: 11785702
[No Abstract] [Full Text] [Related]
10. Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice.
White PJ; Fogarty RD; Liepe IJ; Delaney PM; Werther GA; Wraight CJ
J Invest Dermatol; 1999 Jun; 112(6):887-92. PubMed ID: 10383734
[TBL] [Abstract][Full Text] [Related]
11. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
Oldenburg KR; Vo KT; Smith GA; Selick HE
J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
[TBL] [Abstract][Full Text] [Related]
12. Parameters controlling topical delivery of oligonucleotides by electroporation.
Regnier V; Le Doan T; Préat V
J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977
[TBL] [Abstract][Full Text] [Related]
13. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
Ita K
Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
[TBL] [Abstract][Full Text] [Related]
14. C-5 propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application.
White PJ; Gray AC; Fogarty RD; Sinclair RD; Thumiger SP; Werther GA; Wraight CJ
J Invest Dermatol; 2002 Jun; 118(6):1003-7. PubMed ID: 12060395
[TBL] [Abstract][Full Text] [Related]
15. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
16. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
17. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes.
Brand RM; Haase K; Hannah TL; Iversen PL
J Invest Dermatol; 1998 Dec; 111(6):1166-71. PubMed ID: 9856834
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.
Wingens M; van Hooijdonk CA; de Jongh GJ; Schalkwijk J; van Erp PE
Arch Dermatol Res; 1998 Mar; 290(3):119-25. PubMed ID: 9558486
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide treatments for psoriasis.
White PJ; Atley LM; Wraight CJ
Expert Opin Biol Ther; 2004 Jan; 4(1):75-81. PubMed ID: 14680470
[TBL] [Abstract][Full Text] [Related]
20. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.
Wagner RW; Matteucci MD; Lewis JG; Gutierrez AJ; Moulds C; Froehler BC
Science; 1993 Jun; 260(5113):1510-3. PubMed ID: 7684856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
